Pradžia › Žarnyno vėžys › Florida
Žarnyno vėžys klinikiniai tyrimai Florida
6 tyrimai dėl Žarnyno vėžys ieško dalyvių vietose Florida.
Oficialus tyrimo tekstas (anglų kalba)
Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma
- AdventHealth Orlando, Orlando
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-29 · NCT07845617Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Florida Cancer Specialists, Bonita Springs
- Florida Cancer Specialists, Bradenton
- Comprehensive Hematology Oncology, Brandon
- ir dar 19
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07222800Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Florida Cancer Specialists, Sarasota
- Moffitt Cancer Center and Research Institute, Tampa
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT06128551Integrated Cancer Repository for Cancer Research
- Florida Hospital Memorial Medical Center, Daytona Beach
- Florida Hospital DeLand, DeLand
- Florida Hospital FISH, Orange City
- ir dar 2
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 19 iki 110 · Visoms lytims · Atnaujinta 2026-06-29 · NCT02012699A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Memorial Healthcare System, Hollywood
Renkami dalyviai1/2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-05-27 · NCT03093116Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Moffitt Cancer Center, Tampa
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-15 · NCT05379985Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.